Clinical Trial Update: Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC) [EARLY_Phase 1]

View source ↗

Summary

The clinical trial evaluating a mature dendritic cell vaccine for non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: Washington University School of Medicine | Conditions: Carcinoma, Non-Small-Cell-Lung, Non-Small Cell Lung Cancer | EARLY_Phase 1 | Status: WITHDRAWN